13 Apr 2023
Seeking expressions of interest: DiT vacancy on AMA Board
The AMA is inviting Doctors in Training to nominate for an appointed two-year position on the AMA Board of Directors.
06 Apr 2023
Compliance review vindicates doctors, dismissing claims of widespread rorting
An independent review into Medicare compliance has found no evidence of the $8 billion fraud alleged by the media last year
06 Apr 2023
Medicare freeze strips $4 billion from general practice
The AMA calls on the Government to restore funds stripped from Medicare over years of the rebate freeze and put it back into primary care to address rising patient out-of-pocket costs and struggling general practice.
06 Apr 2023
Online gambling now a pervasive threat that needs to be stopped
In an MJA article this week the AMA President and Chair of Mental Health Committee show online gambling has become a big problem for Australians and urge action to curb the advertising of online gambling products.
08 Apr 2023
Extension of ‘high risk’ GP telehealth exemption for referrals
Updated information from the Department of Health advising of an extension to the exemption with updated factsheets to come soon.
06 Apr 2023
The AMA provides a submission to the Privacy Act Review Consultation
The AMA’s submission to the Attorney General’s Department suggests a nuanced approach rather than ‘one size fits all’ strategy.
06 Apr 2023
AMA calls for safer, healthier and more supportive work environments for hospital doctors
A new position statement from the AMA maintains doctors’ safety and wellbeing at their workplace is closely linked with the quality of care delivered to patients and can impact clinical care outcomes.
06 Apr 2023
The challenges of night shifts
Drs4Drs have some advice for keeping well while working night shifts.
03 Apr 2023
Virtual GP Roundtable – Better than a backup: supporting doctors in training to choose a career in general practice
The outcomes of from the AMA Council of Doctors virtual GP roundtable
30 Mar 2023
Health minister responds to AMA President’s letter on pharmacy trials
The response follows a letter from the AMA President outlining significant concerns with a number of state pharmacy trials.